Sudan wants U.S. compensation for pharma plant bombing

Sudanese remain angry and demand compensation for a pharma plant destroyed during a U.S. missile attack in 1998. The plant was believed by the Clinton administration to be manufacturing chemical weapons and linked to the al Qaida terrorist group, which Sudan denies. The U.S. ordered the attack following the bombing of two U.S. embassies in Africa, says Voice of America. Article

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.

Roche's global manufacturing leader Pierre-Alain Ruffieux will take the reins and oversee the Moderna COVID-19 vaccine collaboration.